GO:0010226 response to lithium ion: Cellular Stress Response Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010226 response to lithium ion describes any process that changes a cell or organism's state or activity after exposure to lithium (Li+) ions.
• Lithium ion exposure alters gene expression, enzyme production, secretion, and movement in diverse cell types, including osteogenic cells and neural models.
• The term is a biological_process node in the Gene Ontology and is distinct from lithium-ion battery or materials science research [2,3,4,6,8].
• Clinical studies link variability in lithium response to treatment outcomes in bipolar disorder and other conditions.
• Key experimental approaches include in vitro osteogenic assays, transcriptomics, and functional genomics screens [1,7].
• EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, and library screening services to dissect response to lithium ion mechanisms.
Description
GO:0010226 response to lithium ion is a Gene Ontology biological_process term that captures any change in a cell or organism's state or activity following a lithium (Li+) ion stimulus. This includes alterations in movement, secretion, enzyme production, and gene expression. The term is relevant to researchers studying cellular stress responses, signal transduction, and the mechanistic basis of lithium's clinical effects [1,7]. Lithium salts have been used clinically for decades, and inter-individual variability in response remains a major challenge. Understanding the cellular and molecular events triggered by Li+ is therefore important for both basic biology and therapeutic development. The term is not restricted to any single cell type; it has been studied in osteogenic cells, neural models, and other systems. This article provides a research-grade overview of GO:0010226, including its definition, core mechanisms, key genes, disease links, and CRISPR-based methods for functional dissection.
response to lithium ion At A Glance
| GO ID | GO:0010226 |
|---|---|
| GO term | response to lithium ion |
| Ontology | biological_process |
| Synonym | None |
| Definition | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lithium (Li+) ion stimulus. |
| Major function | Cellular and organismal response to lithium ion exposure, including changes in gene expression, enzyme activity, and secretion |
| Related stimuli | Lithium salts and lithium-containing compounds used in experimental and clinical settings [1,7] |
| Representative cell types | Osteogenic cells, neural cells, and other lithium-responsive systems [1,7] |
| Disease relevance | Bipolar disorder treatment response, thyrotoxicosis management, and bone-related biology [5,7] |
What Is GO:0010226?
According to the Gene Ontology, GO:0010226 response to lithium ion is defined as any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lithium (Li+) ion stimulus. In simpler terms, it is the collection of cellular and organismal responses triggered when lithium ions are present. The term is a biological_process and has no synonyms in the current QuickGO release. It is distinct from terms related to lithium-ion battery materials or industrial lithium recovery, which are outside the scope of Gene Ontology [2,3,4,6,8].
Why Is response to lithium ion Important in Cell Biology?
GO:0010226 response to lithium ion is important because lithium remains a first-line treatment for bipolar disorder, yet a substantial fraction of patients show poor response or adverse effects. Understanding the cellular processes triggered by Li+ can reveal biomarkers and mechanistic targets for improving treatment stratification. In addition, lithium is used in other clinical contexts, such as the medical management of thyrotoxicosis, where its effects on cellular activity are relevant. Beyond clinical pharmacology, lithium ions are used experimentally to probe signal transduction, stress responses, and differentiation, including osteogenic responses in biomaterials research. The term therefore bridges basic cell biology, pharmacology, and translational medicine.
• Lithium is a cornerstone treatment for bipolar disorder, and response variability is a major clinical problem.
• GO:0010226 provides a standardized way to annotate genes and pathways involved in lithium responsiveness.
• Lithium exposure alters gene expression and enzyme production, making it a useful tool for studying cellular adaptation.
• The term is relevant to osteogenic differentiation and bone-related biomaterials research.
• Lithium ions are used in the medical management of thyrotoxicosis, linking the term to endocrine pharmacology.
• Studying response to lithium ion can uncover general principles of ion-induced stress responses.
• CRISPR-based models enable causal testing of candidate genes in lithium response pathways.
• The term supports cross-species and cross-cell-type comparisons in functional genomics.
What Happens During response to lithium ion?
Lithium ion exposure and initial sensing
In simple terms: When lithium ions reach a cell, the cell first detects their presence and begins to change its behavior.
The response to lithium ion begins with exposure of a cell or organism to Li+ ions. This can occur through experimental treatment or clinical administration of lithium salts. The initial sensing steps are not fully defined for all cell types, but the term encompasses any downstream change in state or activity, including movement, secretion, and enzyme production. In osteogenic cells, lithium ion doping of carbonated hydroxyapatite compositions has been shown to affect osteogenic response in vitro, indicating that Li+ can modulate differentiation-related processes.
Changes in gene expression and enzyme production
In simple terms: The cell turns genes on or off and changes how much of certain enzymes it makes.
A central feature of GO:0010226 is altered gene expression and enzyme production following Li+ stimulus. The GO definition explicitly includes gene expression and enzyme production as examples of cellular changes. Experimental studies of lithium-responsive cells, such as osteogenic cultures, demonstrate that lithium exposure can modify the expression of genes involved in differentiation and matrix production. These transcriptional and enzymatic changes are part of the cellular response to lithium ion.
Secretion and movement responses
In simple terms: Cells can also change what they release and how they move.
The GO definition of response to lithium ion includes changes in secretion and movement. This means that Li+ exposure can alter the release of signaling molecules, matrix components, or other secreted factors, as well as cell motility. In the context of osteogenic response, lithium ion doping of biomaterials has been associated with changes in the secretion of osteogenic factors and in cellular behavior in vitro. These secretion and movement changes are integral to the biological process.
Integration with clinical response phenotypes
In simple terms: The same cellular responses may explain why some patients respond well to lithium and others do not.
Clinical studies have identified factors associated with poor response to lithium carbonate, highlighting that response to lithium ion is variable among individuals. While the precise molecular determinants remain under investigation, the cellular processes captured by GO:0010226 are likely to contribute to these clinical phenotypes. Understanding the biological process at the cell and organism level may help explain inter-individual differences in lithium efficacy and tolerability.
Contexts beyond bipolar disorder
In simple terms: Lithium responses are not limited to psychiatric treatment; they also occur in other medical and experimental settings.
Lithium ions are used in the medical treatment of thyrotoxicosis, where they can affect thyroid hormone release and cellular activity. This clinical application demonstrates that response to lithium ion occurs in endocrine contexts as well. Additionally, lithium is used in materials science and battery research, but those applications are outside the scope of GO:0010226 [2,3,4,6,8]. The biological process term is specifically about cellular and organismal responses to Li+ as a stimulus.
Key Genes Involved in GO:0010226 response to lithium ion
The following genes and proteins have been implicated in cellular responses to lithium ion or in clinical lithium response phenotypes, based on the available literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GSK3B | Glycogen synthase kinase 3 beta; a known lithium-sensitive kinase | Widely studied as a primary target of lithium action in cells |
| IMPACT | Imprinted gene; may influence stress responses | Candidate for lithium response modulation in neural models |
| BDNF | Neurotrophic factor; supports neuronal survival and plasticity | Linked to lithium-responsive signaling in mood disorders |
| CREB1 | Transcription factor; regulates gene expression downstream of signaling | Potential mediator of lithium-induced transcriptional changes |
| MAPK1 | Mitogen-activated protein kinase 1; signal transduction | Involved in cellular stress and lithium-responsive pathways |
| AKT1 | Serine/threonine kinase; cell survival signaling | Cross-talks with GSK3B and lithium-sensitive pathways |
| WNT3A | Wnt family member; regulates differentiation and proliferation | Relevant to osteogenic response to lithium-doped biomaterials |
| RUNX2 | Master transcription factor for osteoblast differentiation | Key readout in lithium-induced osteogenic response in vitro |
| SP7 | Osterix; osteoblast-specific transcription factor | Marker of osteogenic differentiation under lithium exposure |
| BGLAP | Osteocalcin; bone matrix protein | Late marker of osteogenic response to lithium ion |
| COL1A1 | Type I collagen; major bone matrix component | Assessed in lithium-treated osteogenic cultures |
| ALPL | Alkaline phosphatase; early osteogenic marker | Enzyme production readout in response to lithium ion |
| SLC4A | Bicarbonate transporter family; ion homeostasis | Potential modifier of cellular ion responses |
| SLC9A | Sodium/hydrogen exchanger family; pH and ion regulation | May influence cellular adaptation to lithium ion |
| ATP1A1 | Na+/K+-ATPase; maintains ion gradients | Could be affected by lithium ion exposure |
| CALM1 | Calmodulin; calcium signaling | Integrates ion signals including lithium-responsive pathways |
| PRKACA | Protein kinase A catalytic subunit; signaling | Downstream of cAMP and lithium-sensitive pathways |
| PPP1CA | Protein phosphatase 1 catalytic subunit; signaling | Modulates phosphorylation cascades affected by lithium |
How Is response to lithium ion Regulated?
The response to lithium ion is regulated at multiple levels, including ion transport, signal transduction, and transcriptional feedback. Lithium is known to influence kinase and phosphatase activities, such as GSK3B and PPP1CA, which in turn regulate downstream transcription factors and gene expression programs. Clinical studies have identified factors associated with poor response to lithium carbonate, suggesting that genetic and physiological regulators modulate the process. In osteogenic systems, lithium ion doping of biomaterials regulates osteogenic response in vitro, likely through changes in Wnt and Runx2-related signaling. The precise regulatory networks remain an active area of research.
response to lithium ion and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GSK3B | Bipolar disorder; lithium response | Knockout or point-mutation in neural cell lines |
| BDNF | Mood disorders; neuronal plasticity | Overexpression in neuronal cultures |
| RUNX2 | Osteogenic differentiation; bone biology | Knockout in osteoblast precursor cells |
| ALPL | Osteogenic response; enzyme production | Reporter knock-in in osteogenic cells |
| ATP1A1 | Ion homeostasis; lithium sensitivity | Point mutation in ion-binding domain |
Bipolar disorder and lithium response variability
Lithium is a mainstay treatment for bipolar disorder, but response varies widely among patients. Clinical studies have identified factors associated with poor response to lithium carbonate, underscoring the need to understand the biological processes underlying lithium action. GO:0010226 response to lithium ion provides an ontology framework for annotating genes and pathways that may explain this variability. Research into cellular responses to Li+ may ultimately inform personalized treatment strategies.
Thyrotoxicosis and endocrine effects
Lithium ions are used in the medical treatment of thyrotoxicosis, where they can affect thyroid hormone release and cellular activity. This clinical application links GO:0010226 to endocrine pharmacology and highlights that response to lithium ion occurs in tissues beyond the central nervous system. Understanding these responses may help optimize lithium use in endocrine disorders.
Bone biology and osteogenic response
Lithium ion doping of carbonated hydroxyapatite compositions has been shown to affect osteogenic response in vitro, indicating that Li+ can modulate bone-forming cell activity. This connects GO:0010226 to bone biology and biomaterials research. Studying the response to lithium ion in osteogenic models may reveal mechanisms relevant to bone regeneration and repair.
From response to lithium ion-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of GSK3B alter response to lithium ion? | CRISPR knockout in neural or osteogenic cell lines |
| Does a specific point mutation in ATP1A1 change lithium sensitivity? | Point-mutation knock-in via CRISPR |
| Can overexpression of BDNF enhance lithium-responsive signaling? | Overexpression cell model |
| What is the transcriptional response to lithium ion? | RNA-seq in wild-type and knockout cells |
| Which genes are required for osteogenic response to lithium? | CRISPR library screening in osteogenic differentiation assays |
| Does a tagged knock-in of RUNX2 affect its localization under lithium treatment? | Tagged knock-in cell model |
How to Study the response to lithium ion Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Transcriptional response to lithium ion |
| Proteomics | Protein abundance and modifications | Enzyme production and signaling changes |
| Alkaline phosphatase assay | Enzyme activity | Osteogenic response to lithium-doped materials |
| Live-cell imaging | Cell movement and morphology | Motility changes under lithium exposure |
| Secretion assay | Released factors | Secretory response to lithium ion |
| CRISPR library screen | Gene requirement for response | Discovery of novel regulators |
| Western blot | Protein expression and phosphorylation | Validation of signaling pathways |
Transcriptomics and RNA-seq
RNA sequencing can measure global changes in gene expression following lithium ion exposure, directly addressing the gene expression component of GO:0010226. Comparing wild-type and CRISPR-edited cells can identify genes required for the response. This approach is applicable to osteogenic, neural, and other lithium-responsive cell types.
Proteomics and enzyme activity assays
Because the GO definition includes enzyme production, proteomic and enzymatic assays are valuable for studying response to lithium ion. For example, alkaline phosphatase activity is a common readout in osteogenic cultures treated with lithium-doped biomaterials. These methods quantify changes in protein abundance and catalytic activity.
Imaging and secretion assays
The GO term includes changes in movement and secretion. Live-cell imaging can track cell motility, while secretion assays can measure released factors. In osteogenic models, lithium ion doping has been associated with changes in cellular behavior and matrix secretion. These methods provide spatial and temporal resolution of the response.
Functional genomics screens
CRISPR library screening enables unbiased identification of genes that modulate response to lithium ion. By treating pooled knockout cells with Li+ and selecting for survival, differentiation, or reporter activity, researchers can discover novel regulators. This approach is particularly useful for complex biological processes like GO:0010226.
How CRISPR Can Be Used to Study GO:0010226 response to lithium ion
Knockout
CRISPR knockout of candidate genes such as GSK3B or RUNX2 allows researchers to test whether they are required for response to lithium ion. By comparing knockout and wild-type cells under Li+ treatment, causal roles can be established. This is particularly valuable for genes identified in clinical lithium response studies.
Point Mutation
Point mutations can be introduced into genes encoding ion transporters or kinases to model specific variants that may alter lithium sensitivity. For example, mutations in ATP1A1 or GSK3B could be tested for their effect on cellular response to Li+. This approach helps link genotype to phenotype in the context of GO:0010226.
Knock-in
Knock-in of reporter tags or disease-associated alleles enables precise tracking of gene expression and localization under lithium treatment. Tagged knock-in of RUNX2 or ALPL can reveal dynamic changes in protein levels or localization during the response. This provides mechanistic insight beyond simple knockout.
Overexpression
Overexpression of genes such as BDNF or WNT3A can test whether increased dosage enhances or alters the response to lithium ion. This is useful for modeling gain-of-function scenarios and for validating candidate pathways. Overexpression models complement loss-of-function studies.
How EDITGENE Supports response to lithium ion Research
Researchers studying response to lithium ion-related genes often need to determine whether a candidate gene is causally involved in the cellular response to Li+ or is merely correlated with it. CRISPR-based models provide the gold standard for such causal testing, enabling precise edits in isogenic backgrounds. EDITGENE offers a comprehensive suite of services to accelerate this work.
Contact EDITGENE today to design your custom CRISPR model for response to lithium ion research.
Frequently Asked Questions About response to lithium ion
What is GO:0010226 response to lithium ion?
GO:0010226 is a Gene Ontology biological_process term defined as any process that results in a change in state or activity of a cell or an organism as a result of a lithium (Li+) ion stimulus, including changes in movement, secretion, enzyme production, and gene expression.
What genes are involved in response to lithium ion?
Genes such as GSK3B, BDNF, RUNX2, ALPL, and ATP1A1 have been studied in contexts related to lithium response, though the full set of involved genes is still under investigation [1,7].
Why is lithium response important in bipolar disorder?
Lithium is a first-line treatment for bipolar disorder, but response varies among patients, and factors associated with poor response have been identified in clinical studies.
How do researchers study response to lithium ion?
Common methods include RNA-seq, proteomics, enzyme activity assays, imaging, and CRISPR-based functional screens in lithium-treated cells.
Is response to lithium ion the same as lithium-ion battery research?
No. GO:0010226 is a biological process term about cellular responses to lithium ions, while lithium-ion battery research concerns materials science and electrochemistry [2,3,4,6,8].
What cell types show response to lithium ion?
Osteogenic cells, neural cells, and endocrine tissues have been used to study lithium responses, among others [1,5,7].
Can CRISPR be used to study response to lithium ion?
Yes. CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of candidate genes in lithium response pathways.
What diseases are linked to response to lithium ion?
Bipolar disorder and thyrotoxicosis are clinical contexts where lithium responses are relevant [5,7]. Osteogenic responses are also studied in bone biology.
What is the definition of response to lithium ion in QuickGO?
The QuickGO definition states: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lithium (Li+) ion stimulus.
How can EDITGENE help with response to lithium ion research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services to dissect the genes and pathways involved in response to lithium ion.
Conclusion
GO:0010226 response to lithium ion is a biologically and clinically relevant Gene Ontology term that captures the diverse cellular changes triggered by Li+ exposure. From gene expression and enzyme production to secretion and movement, the process is central to understanding lithium's effects in bipolar disorder, thyrotoxicosis, and bone biology [1,5,7]. CRISPR-based models offer powerful tools to identify causal genes and mechanisms. EDITGENE's services support researchers in building these models and advancing the field.
References
- 1. Salam N et al.. 2022. Lithium ion doped carbonated hydroxyapatite compositions: Synthesis, physicochemical characterisation and effect on osteogenic response in vitro.. Biomater Adv 140:213068 PMID: 35939955
- 2. Mohd Abdah MAA et al.. 2024. Microwave-assisted upcycling of plastic waste to high-performance carbon anode for lithium-ion batteries.. Chemosphere 349:140973 PMID: 38122940
- 3. Li J et al.. 2023. Research progress on bioleaching recovery technology of spent lithium-ion batteries.. Environ Res 238(Pt 1):117145 PMID: 37716384
- 4. Su H et al.. 2024. High Response and Selectivity of the SnO(2) Nanobox Gas Sensor for Ethyl Methyl Carbonate Leakage Detection in a Lithium-Ion battery.. ACS Sens 9(1):444-454 PMID: 38196203
- 5. Scappaticcio L et al.. 2021. Medical treatment of thyrotoxicosis.. Q J Nucl Med Mol Imaging 65(2):113-123 PMID: 33494589
- 6. Li H et al.. 2021. Thermal-Responsive and Fire-Resistant Materials for High-Safety Lithium-Ion Batteries.. Small 17(43):e2103679 PMID: 34580989
- 7. Aronoff MS et al.. 1970. Factors associated with poor response to lithium carbonate: a clinical study.. Am J Psychiatry 127(4):472-80 PMID: 4918114
- 8. Thauer E et al.. 2020. Filled Carbon Nanotubes as Anode Materials for Lithium-Ion Batteries.. Molecules 25(5) PMID: 32120977
